REGAL REXNORD CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data REGAL REXNORD CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,225	3,360	3,646	3,238	2,907	3,810	5,218	6,251	6,034	5,935
Cost of revenue	2,360	2,477	2,681	2,377	2,100	2,699	3,548	4,183	3,843	3,717
Gross profit	865	884	965	861	807	1,112	1,670	2,067	2,191	2,218
Research and development	29.5	29.9	29.3	64.6	67	74.5	107	171	176	199
Operating expenses	543	553	599	544	513	715	979	1,690	1,561	1,537
Operating income	323	331	347	351	278	358	690	377	630	681
Interest expense	58.7	56.1	55.2	53	39.8	60.4	87.2	431	400	349
Interest income	4.5	3.2	1.9	5.6	5.9	7.4	5.2	43.6	18.8	23.7
Other non-operating income		-1	-1.5	0.1	4.4	5.2	5.4	8.7	-1.1	-2.8
Pre-tax income	266	277	292	304	249	311	614	-1.6	248	353
Income tax	57.1	59.1	56.4	61.2	56.3	74.7	119	52.7	49.6	71.7
Net income to minority interests	5.9	5.1	4.6	3.7	4.5	6.2	6	3.1	2.2	1.3
Net income	203	213	231	239	188	230	489	-57.4	196	280
EBITDA	478	468	489	486	409	529	998	870	795	835
EPS, basic	4.55	4.78	5.30	5.69	4.62	4.85	7.33	-0.87	2.96	4.22
EPS, diluted	4.52	4.74	5.26	5.66	4.60	4.81	7.29	-0.87	2.94	4.20
Shares, basic (weighted)	44.7	44.6	43.6	42	40.6	47.3	66.7	66.3	66.4	66.3
Shares, diluted (weighted)	45	44.9	43.9	42.2	40.8	47.7	67.1	66.3	66.7	66.6
Dividend per share	0.95	1.02	1.10	1.18	1.20	8.28	1.38	1.38	1.40	1.40

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	285	140	249	331	611	673	689	574	394	522
Receivables	462	506	552	461	432	786	797	922	843	524
Inventory	661	757	767	678	690	1,192	1,337	1,274	1,228	1,322
Other current assets	125	171	158	134	109	145	151	246	288	345
Total current assets	1,532	1,574	1,818	1,608	1,851	2,809	3,001	3,384	2,751	2,712
Property, plant and equipment	628	623	616	605	556	909	807	1,041	921	912
Lease right-of-use assets			0	71	73.4	112	111	173	141	145
Goodwill	1,453	1,477	1,509	1,501	1,518	4,039	4,019	6,553	6,459	6,611
Intangible assets	1,071	1,094	626	567	530	2,429	2,230	4,083	3,665	3,418
Other non-current assets	11.7	14.7	21.7	20.1	16.4	33.8	57.9	69	66.7	85.8
Total assets	4,359	4,388	4,624	4,431	4,589	10,367	10,269	15,431	14,034	13,921
Accounts payable	334	384	425	337	360	644	498	549	543	607
Accrued liabilities	70.1	74.2	81.9	67.3	76.6	144	141	199	191	206
Deferred revenue										34.5
Short-term debt	101	101	0.5	0.6	231	4.9	33.8	3.9	5	24.1
Total current liabilities	702	712	684	561	822	1,095	1,002	1,326	1,216	1,264
Long-term debt	1,311	1,040	1,307	1,137	840	1,914	1,990	6,377	5,453	4,765
Lease liabilities			0	51	55.1	89.5	88.1	132	114	114
Other non-current liabilities	46	44.4	49.5	49.2	53	69.4	76.8	77.2	59	66.2
Total liabilities	2,280	2,034	2,285	2,010	1,974	3,959	3,846	9,066	7,767	7,068
Total debt	1,412	1,141	1,307	1,138	1,071	1,919	2,024	6,381	5,500	4,819
Paid-in capital	905	878	784	702	697	4,652	4,610	4,646	4,658	4,689
Retained earnings	1,452	1,612	1,778	1,887	2,011	1,913	2,130	1,980	2,044	2,230
Other comprehensive income	-318	-164	-251	-238	-163	-195	-352	-282	-443	-75.4
Shareholders' equity	2,039	2,326	2,311	2,351	2,544	6,370	6,388	6,344	6,260	6,844
Minority interests	39.4	29.2	28	29.3	32.6	38.2	34.4	20.8	7.4	9.2
Total equity	2,078	2,355	2,339	2,420	2,615	6,408	6,423	6,365	6,267	6,853
Total liabilities and equity	4,359	4,388	4,624	4,431	4,589	10,367	10,269	15,431	14,034	13,921
Shares outstanding	44.8	44.3	42.8	40.8	40.6	67.6	66.2	66.3	66.3	66.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	209	218	236	243	192	236	495	-54.3	198	281
Depreciation and amortization	155	137	142	135	131	171	307	493	165	155
Stock-based compensation	13.3	13.6	16.9	13	9.2	24.9	22.5	58.2	34.8	37.3
Deferred income tax	0.1	-9.7	13.2	22.4	-17	-8.7	-80.1	-115	-152	-97.2
Change in receivables	-10.4	-31	-56.5	70.3	29.6	-155	-38.1	51.7	23	345
Change in inventory	100	-83	-42.7	68.6	-1.6	-174	-174	263	23.9	-62.7
Change in payables	7.6	37.7	41.1	-80.3	15.2	157	-130	-70.1	-0.4	45.1
Cash from operations	442	292	363	409	435	358	436	715	609	991
Capital expenditures	-65.2	-65.2	-77.6	-92.4	-47.5	-54.5	-83.8	-119	-110	-97.7
Acquisitions	0	0	-162	0	0	-126	-35	-4,870	0	0
Purchases of investments	-53.7	-0.9	0	0
Cash from investing	-19.6	-57.8	-228	74.3	-37	-176	-113	-4,983	275	-71
Debt issued	0.2	0.3	900	0	0.1	0
Debt repaid	-324	-277	-811	-90.3	-50.4	-451
Stock issued	0.5	0.4	0	0.3	0.2	2.6	5.1	3.3	4.9	2
Share buybacks	0	-45.1	-128	-165	-25	-25.8	-239	0	-50	0
Dividends paid	-42.1	-44.5	-47.2	-48.9	-48.7	-336	-90.9	-92.8	-93	-93
Cash from financing	-380	-391	-17.7	-397	-148	-118	-274	4,204	-1,096	-814
Exchange rate effect	-11.6	11.6	-8.1	-2.6	29.1	-2.9	-33	10.9	-30.8	22.5
Net change in cash	31.6	-145	109	82.8	280	61.5	15.7	-53.2	-242	128
Free cash flow	377	227	285	316	388	303	352	596	500	893
Interest paid	53.7	53.7	54.2	51.7	38.6	35.2	66.7	320	380	312
Income taxes paid	66.9	66.9	81.2	42.3	44.3	103	188	207	177	189

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $156.18 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	37.8%	Gross profit / revenue.
Operating margin	11.7%	Operating income / revenue.
EBITDA margin	14.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	6.6%	Pre-tax income / revenue.
Net margin	5.3%	Net income / revenue.
FCF margin	7.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.2%	Cash from operations / revenue.
Effective tax rate	18.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.4%	Net income / average total assets.
Return on invested capital (ROIC)	5.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.5%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	15.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	1.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	22.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	8.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-0.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	19.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	5.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-5.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	15.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	42.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-17.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	8.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	42.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-16.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-1.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	62.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	31.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	17.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	78.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	36.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	18.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.5%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	3.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	9.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	21.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	10.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	24.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	10.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.28x	Current assets / current liabilities.
Quick ratio	0.82x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.36x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.67x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	33.5%	Total debt / total assets.
Liabilities / assets	49.7%	Total liabilities / total assets.
Net debt	$4.17B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.84x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.13x	Operating income / interest expense.
Working capital	$1.58B	Current assets - current liabilities.
Goodwill and intangibles / assets	71.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$2.89B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.44x	Revenue / average total assets.
Fixed asset turnover	6.97x	Revenue / average property, plant and equipment.
Inventory turnover	2.74x	Cost of revenue / average inventory.
Days inventory	133 days	365 x average inventory / cost of revenue.
Receivables turnover	10.4x	Revenue / average receivables.
Days sales outstanding	35 days	365 x average receivables / revenue.
Days payables	62 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	106 days	Days inventory + days sales outstanding - days payables.
FCF conversion	144.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	16.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.84	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$90.55	Revenue / diluted weighted shares.
FCF per share	$6.97	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.32	Cash from operations / diluted weighted shares.
Book value per share	$103.84	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$43.41	Tangible book value / shares outstanding.
Cash per share	$6.63	(Cash + short-term investments) / shares outstanding.
Payout ratio	28.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	19.9%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$10.40B	Share price x shares outstanding.
Enterprise value	$14.57B	Market cap + total debt - cash - short-term investments.
P/E	32.1x	Market cap / net income. Only when net income is positive.
P/S	1.72x	Market cap / revenue.
P/B	1.50x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	22.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	18.7x	Market cap / cash from operations, when positive.
EV/Sales	2.41x	Enterprise value / revenue.
EV/EBIT	20.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	31.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	4.5%	Free cash flow / market cap.
Earnings yield	3.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.9%	Dividends paid over the period / market cap.
Shareholder yield	0.9%	(Dividends paid + share buybacks) / market cap.

What was REGAL REXNORD CORP's revenue in fiscal 2025?

REGAL REXNORD CORP reported revenue of $5.93B for fiscal 2025, 1.6% lower than the year before.

Was REGAL REXNORD CORP profitable in fiscal 2025?

Yes. Net income was $279.5M, a net margin of 4.7%.

How much free cash flow did REGAL REXNORD CORP generate in fiscal 2025?

Cash from operations of $990.8M minus capital expenditures of $97.7M left free cash flow of $893.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to REGAL REXNORD CORP